Reports

Industry Research Reports

Automatic Peptide Continuous Synthesizer- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Automatic Peptide Continuous Synthesizer- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Medical Devices & Consumables

Published Date: 2025-01-13

Pages: 123 Pages

Report ld: 3501841

application for samples

Request Sample

Custom reports

Customized Report

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

Automatic Peptide Continuous Synthesizer Market Size(US$)

den_QYR1
cagr

CAGR 2025-2031

2.6%

marketSize

Market Size,2031

USD 91.9

Million

Market Snapshot

Market Size in 2025 (Value)
US$ 78.7 million
Market Forecast in 2031(Value)
US$ 91.9 million
CAGR
2.6%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Automatic Peptide Continuous Synthesizer was estimated to be worth US$ 76.9 million in 2024 and is forecast to a readjusted size of US$ 91.9 million by 2031 with a CAGR of 2.6% during the forecast period 2025-2031.

North American market for Automatic Peptide Continuous Synthesizer was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Automatic Peptide Continuous Synthesizer was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Automatic Peptide Continuous Synthesizer was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global key companies of Automatic Peptide Continuous Synthesizer include Gyros Protein Technologies AB, Büchi AG, Biotage, CEM, CSBio, AAPPTec, Activotec, MultiSynTech, NJ Biopharmaceuticals LLC, Peptide Machines, Inc., etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for Automatic Peptide Continuous Synthesizer, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Automatic Peptide Continuous Synthesizer by region & country, by Type, and by Application.

The Automatic Peptide Continuous Synthesizer market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Automatic Peptide Continuous Synthesizer.

MARKET SEGMENTATION

By Company

  • Gyros Protein Technologies AB
  • Büchi AG
  • Biotage
  • CEM
  • CSBio
  • AAPPTec
  • Activotec
  • MultiSynTech
  • NJ Biopharmaceuticals LLC
  • Peptide Machines, Inc.
  • Protein Technologies, Inc.
  • Intavis AG

Consumption by Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Segment by Type

  • Fully Automatic
  • Aemi-automatic
  • Manual

Segment by Application

  • Laboratory
  • University
  • Research Center

biaoTi CHAPTER OUTLINE

marn_i1

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

marn_i1

Chapter 2: Detailed analysis of Automatic Peptide Continuous Synthesizer manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

marn_i1

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

marn_i1

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

marn_i1

Chapter 5: Sales, revenue of Automatic Peptide Continuous Synthesizer in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

marn_i1

Chapter 6: Sales, revenue of Automatic Peptide Continuous Synthesizer in country level. It provides sigmate data by Type, and by Application for each country/region.

marn_i1

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

marn_i1

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

marn_i1

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region
Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

den_ic6
Product mix optimization based on local practices
Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

den_ic6
Competitor tactics in fragmented vs. consolidated markets
Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

den_ic6
Full Research Coverage
Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

den_ic6
19 Years Industry Expertise
19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

den_ic6
24/7 Fast Report Delivery
24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

den_ic6
Localized Strategic Analysis
Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

den_ic6
den_biaoTiZhungShi

TABLE OF CONTENTS

muLu

1 Market Overview

1.1 Automatic Peptide Continuous Synthesizer Product Introduction

1.2 Global Automatic Peptide Continuous Synthesizer Market Size Forecast

1.2.1 Global Automatic Peptide Continuous Synthesizer Sales Value (2020-2031)

1.2.2 Global Automatic Peptide Continuous Synthesizer Sales Volume (2020-2031)

1.2.3 Global Automatic Peptide Continuous Synthesizer Sales Price (2020-2031)

1.3 Automatic Peptide Continuous Synthesizer Market Trends & Drivers

1.3.1 Automatic Peptide Continuous Synthesizer Industry Trends

1.3.2 Automatic Peptide Continuous Synthesizer Market Drivers & Opportunity

1.3.3 Automatic Peptide Continuous Synthesizer Market Challenges

1.3.4 Automatic Peptide Continuous Synthesizer Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

muLu

2 Competitive Analysis by Company

2.1 Global Automatic Peptide Continuous Synthesizer Players Revenue Ranking (2024)

2.2 Global Automatic Peptide Continuous Synthesizer Revenue by Company (2020-2025)

2.3 Global Automatic Peptide Continuous Synthesizer Players Sales Volume Ranking (2024)

2.4 Global Automatic Peptide Continuous Synthesizer Sales Volume by Company Players (2020-2025)

2.5 Global Automatic Peptide Continuous Synthesizer Average Price by Company (2020-2025)

2.6 Key Manufacturers Automatic Peptide Continuous Synthesizer Manufacturing Base and Headquarters

2.7 Key Manufacturers Automatic Peptide Continuous Synthesizer Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Automatic Peptide Continuous Synthesizer

2.9 Automatic Peptide Continuous Synthesizer Market Competitive Analysis

2.9.1 Automatic Peptide Continuous Synthesizer Market Concentration Rate (2020-2025)

2.9.2 Global 5 and 10 Largest Manufacturers by Automatic Peptide Continuous Synthesizer Revenue in 2024

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Automatic Peptide Continuous Synthesizer as of 2024)

2.10 Mergers & Acquisitions, Expansion

muLu

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Fully Automatic

3.1.2 Aemi-automatic

3.1.3 Manual

3.2 Global Automatic Peptide Continuous Synthesizer Sales Value by Type

3.2.1 Global Automatic Peptide Continuous Synthesizer Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Automatic Peptide Continuous Synthesizer Sales Value, by Type (2020-2031)

3.2.3 Global Automatic Peptide Continuous Synthesizer Sales Value, by Type (%) (2020-2031)

3.3 Global Automatic Peptide Continuous Synthesizer Sales Volume by Type

3.3.1 Global Automatic Peptide Continuous Synthesizer Sales Volume by Type (2020 VS 2024 VS 2031)

3.3.2 Global Automatic Peptide Continuous Synthesizer Sales Volume, by Type (2020-2031)

3.3.3 Global Automatic Peptide Continuous Synthesizer Sales Volume, by Type (%) (2020-2031)

3.4 Global Automatic Peptide Continuous Synthesizer Average Price by Type (2020-2031)

muLu

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Laboratory

4.1.2 University

4.1.3 Research Center

4.2 Global Automatic Peptide Continuous Synthesizer Sales Value by Application

4.2.1 Global Automatic Peptide Continuous Synthesizer Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global Automatic Peptide Continuous Synthesizer Sales Value, by Application (2020-2031)

4.2.3 Global Automatic Peptide Continuous Synthesizer Sales Value, by Application (%) (2020-2031)

4.3 Global Automatic Peptide Continuous Synthesizer Sales Volume by Application

4.3.1 Global Automatic Peptide Continuous Synthesizer Sales Volume by Application (2020 VS 2024 VS 2031)

4.3.2 Global Automatic Peptide Continuous Synthesizer Sales Volume, by Application (2020-2031)

4.3.3 Global Automatic Peptide Continuous Synthesizer Sales Volume, by Application (%) (2020-2031)

4.4 Global Automatic Peptide Continuous Synthesizer Average Price by Application (2020-2031)

muLu

5 Segmentation by Region

5.1 Global Automatic Peptide Continuous Synthesizer Sales Value by Region

5.1.1 Global Automatic Peptide Continuous Synthesizer Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Automatic Peptide Continuous Synthesizer Sales Value by Region (2020-2025)

5.1.3 Global Automatic Peptide Continuous Synthesizer Sales Value by Region (2026-2031)

5.1.4 Global Automatic Peptide Continuous Synthesizer Sales Value by Region (%), (2020-2031)

5.2 Global Automatic Peptide Continuous Synthesizer Sales Volume by Region

5.2.1 Global Automatic Peptide Continuous Synthesizer Sales Volume by Region: 2020 VS 2024 VS 2031

5.2.2 Global Automatic Peptide Continuous Synthesizer Sales Volume by Region (2020-2025)

5.2.3 Global Automatic Peptide Continuous Synthesizer Sales Volume by Region (2026-2031)

5.2.4 Global Automatic Peptide Continuous Synthesizer Sales Volume by Region (%), (2020-2031)

5.3 Global Automatic Peptide Continuous Synthesizer Average Price by Region (2020-2031)

5.4 North America

5.4.1 North America Automatic Peptide Continuous Synthesizer Sales Value, 2020-2031

5.4.2 North America Automatic Peptide Continuous Synthesizer Sales Value by Country (%), 2024 VS 2031

5.5 Europe

5.5.1 Europe Automatic Peptide Continuous Synthesizer Sales Value, 2020-2031

5.5.2 Europe Automatic Peptide Continuous Synthesizer Sales Value by Country (%), 2024 VS 2031

5.6 Asia Pacific

5.6.1 Asia Pacific Automatic Peptide Continuous Synthesizer Sales Value, 2020-2031

5.6.2 Asia Pacific Automatic Peptide Continuous Synthesizer Sales Value by Region (%), 2024 VS 2031

5.7 South America

5.7.1 South America Automatic Peptide Continuous Synthesizer Sales Value, 2020-2031

5.7.2 South America Automatic Peptide Continuous Synthesizer Sales Value by Country (%), 2024 VS 2031

5.8 Middle East & Africa

5.8.1 Middle East & Africa Automatic Peptide Continuous Synthesizer Sales Value, 2020-2031

5.8.2 Middle East & Africa Automatic Peptide Continuous Synthesizer Sales Value by Country (%), 2024 VS 2031

muLu

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Automatic Peptide Continuous Synthesizer Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Automatic Peptide Continuous Synthesizer Sales Value

6.2.1 Key Countries/Regions Automatic Peptide Continuous Synthesizer Sales Value, 2020-2031

6.2.2 Key Countries/Regions Automatic Peptide Continuous Synthesizer Sales Volume, 2020-2031

6.3 United States

6.3.1 United States Automatic Peptide Continuous Synthesizer Sales Value, 2020-2031

6.3.2 United States Automatic Peptide Continuous Synthesizer Sales Value by Type (%), 2024 VS 2031

6.3.3 United States Automatic Peptide Continuous Synthesizer Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe Automatic Peptide Continuous Synthesizer Sales Value, 2020-2031

6.4.2 Europe Automatic Peptide Continuous Synthesizer Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe Automatic Peptide Continuous Synthesizer Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China Automatic Peptide Continuous Synthesizer Sales Value, 2020-2031

6.5.2 China Automatic Peptide Continuous Synthesizer Sales Value by Type (%), 2024 VS 2031

6.5.3 China Automatic Peptide Continuous Synthesizer Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan Automatic Peptide Continuous Synthesizer Sales Value, 2020-2031

6.6.2 Japan Automatic Peptide Continuous Synthesizer Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan Automatic Peptide Continuous Synthesizer Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Automatic Peptide Continuous Synthesizer Sales Value, 2020-2031

6.7.2 South Korea Automatic Peptide Continuous Synthesizer Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea Automatic Peptide Continuous Synthesizer Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Automatic Peptide Continuous Synthesizer Sales Value, 2020-2031

6.8.2 Southeast Asia Automatic Peptide Continuous Synthesizer Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia Automatic Peptide Continuous Synthesizer Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India Automatic Peptide Continuous Synthesizer Sales Value, 2020-2031

6.9.2 India Automatic Peptide Continuous Synthesizer Sales Value by Type (%), 2024 VS 2031

6.9.3 India Automatic Peptide Continuous Synthesizer Sales Value by Application, 2024 VS 2031

muLu

7 Company Profiles

7.1 Gyros Protein Technologies AB

7.1.1 Gyros Protein Technologies AB Company Information

7.1.2 Gyros Protein Technologies AB Introduction and Business Overview

7.1.3 Gyros Protein Technologies AB Automatic Peptide Continuous Synthesizer Sales, Revenue, Price and Gross Margin (2020-2025)

7.1.4 Gyros Protein Technologies AB Automatic Peptide Continuous Synthesizer Product Offerings

7.1.5 Gyros Protein Technologies AB Recent Development

7.2 Büchi AG

7.2.1 Büchi AG Company Information

7.2.2 Büchi AG Introduction and Business Overview

7.2.3 Büchi AG Automatic Peptide Continuous Synthesizer Sales, Revenue, Price and Gross Margin (2020-2025)

7.2.4 Büchi AG Automatic Peptide Continuous Synthesizer Product Offerings

7.2.5 Büchi AG Recent Development

7.3 Biotage

7.3.1 Biotage Company Information

7.3.2 Biotage Introduction and Business Overview

7.3.3 Biotage Automatic Peptide Continuous Synthesizer Sales, Revenue, Price and Gross Margin (2020-2025)

7.3.4 Biotage Automatic Peptide Continuous Synthesizer Product Offerings

7.3.5 Biotage Recent Development

7.4 CEM

7.4.1 CEM Company Information

7.4.2 CEM Introduction and Business Overview

7.4.3 CEM Automatic Peptide Continuous Synthesizer Sales, Revenue, Price and Gross Margin (2020-2025)

7.4.4 CEM Automatic Peptide Continuous Synthesizer Product Offerings

7.4.5 CEM Recent Development

7.5 CSBio

7.5.1 CSBio Company Information

7.5.2 CSBio Introduction and Business Overview

7.5.3 CSBio Automatic Peptide Continuous Synthesizer Sales, Revenue, Price and Gross Margin (2020-2025)

7.5.4 CSBio Automatic Peptide Continuous Synthesizer Product Offerings

7.5.5 CSBio Recent Development

7.6 AAPPTec

7.6.1 AAPPTec Company Information

7.6.2 AAPPTec Introduction and Business Overview

7.6.3 AAPPTec Automatic Peptide Continuous Synthesizer Sales, Revenue, Price and Gross Margin (2020-2025)

7.6.4 AAPPTec Automatic Peptide Continuous Synthesizer Product Offerings

7.6.5 AAPPTec Recent Development

7.7 Activotec

7.7.1 Activotec Company Information

7.7.2 Activotec Introduction and Business Overview

7.7.3 Activotec Automatic Peptide Continuous Synthesizer Sales, Revenue, Price and Gross Margin (2020-2025)

7.7.4 Activotec Automatic Peptide Continuous Synthesizer Product Offerings

7.7.5 Activotec Recent Development

7.8 MultiSynTech

7.8.1 MultiSynTech Company Information

7.8.2 MultiSynTech Introduction and Business Overview

7.8.3 MultiSynTech Automatic Peptide Continuous Synthesizer Sales, Revenue, Price and Gross Margin (2020-2025)

7.8.4 MultiSynTech Automatic Peptide Continuous Synthesizer Product Offerings

7.8.5 MultiSynTech Recent Development

7.9 NJ Biopharmaceuticals LLC

7.9.1 NJ Biopharmaceuticals LLC Company Information

7.9.2 NJ Biopharmaceuticals LLC Introduction and Business Overview

7.9.3 NJ Biopharmaceuticals LLC Automatic Peptide Continuous Synthesizer Sales, Revenue, Price and Gross Margin (2020-2025)

7.9.4 NJ Biopharmaceuticals LLC Automatic Peptide Continuous Synthesizer Product Offerings

7.9.5 NJ Biopharmaceuticals LLC Recent Development

7.10 Peptide Machines, Inc.

7.10.1 Peptide Machines, Inc. Company Information

7.10.2 Peptide Machines, Inc. Introduction and Business Overview

7.10.3 Peptide Machines, Inc. Automatic Peptide Continuous Synthesizer Sales, Revenue, Price and Gross Margin (2020-2025)

7.10.4 Peptide Machines, Inc. Automatic Peptide Continuous Synthesizer Product Offerings

7.10.5 Peptide Machines, Inc. Recent Development

7.11 Protein Technologies, Inc.

7.11.1 Protein Technologies, Inc. Company Information

7.11.2 Protein Technologies, Inc. Introduction and Business Overview

7.11.3 Protein Technologies, Inc. Automatic Peptide Continuous Synthesizer Sales, Revenue, Price and Gross Margin (2020-2025)

7.11.4 Protein Technologies, Inc. Automatic Peptide Continuous Synthesizer Product Offerings

7.11.5 Protein Technologies, Inc. Recent Development

7.12 Intavis AG

7.12.1 Intavis AG Company Information

7.12.2 Intavis AG Introduction and Business Overview

7.12.3 Intavis AG Automatic Peptide Continuous Synthesizer Sales, Revenue, Price and Gross Margin (2020-2025)

7.12.4 Intavis AG Automatic Peptide Continuous Synthesizer Product Offerings

7.12.5 Intavis AG Recent Development

muLu

8 Industry Chain Analysis

8.1 Automatic Peptide Continuous Synthesizer Industrial Chain

8.2 Automatic Peptide Continuous Synthesizer Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Automatic Peptide Continuous Synthesizer Sales Model

8.5.2 Sales Channel

8.5.3 Automatic Peptide Continuous Synthesizer Distributors

muLu

9 Research Findings and Conclusion

muLu

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

den_biaoTiZhungShi

TABLE OF FIGURES

muLu

List of Tables

Table 1. Automatic Peptide Continuous Synthesizer Market Trends
Table 2. Automatic Peptide Continuous Synthesizer Market Drivers & Opportunity
Table 3. Automatic Peptide Continuous Synthesizer Market Challenges
Table 4. Automatic Peptide Continuous Synthesizer Market Restraints
Table 5. Global Automatic Peptide Continuous Synthesizer Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Automatic Peptide Continuous Synthesizer Revenue Market Share by Company (2020-2025)
Table 7. Global Automatic Peptide Continuous Synthesizer Sales Volume by Company (2020-2025) & (K Units)
Table 8. Global Automatic Peptide Continuous Synthesizer Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Automatic Peptide Continuous Synthesizer Price by Company (2020-2025) & (US$/Unit)
Table 10. Key Manufacturers Automatic Peptide Continuous Synthesizer Manufacturing Base and Headquarters
Table 11. Key Manufacturers Automatic Peptide Continuous Synthesizer Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Automatic Peptide Continuous Synthesizer
Table 13. Global Automatic Peptide Continuous Synthesizer Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Automatic Peptide Continuous Synthesizer as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Automatic Peptide Continuous Synthesizer Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Automatic Peptide Continuous Synthesizer Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Automatic Peptide Continuous Synthesizer Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Automatic Peptide Continuous Synthesizer Sales Market Share in Value by Type (2020-2025)
Table 20. Global Automatic Peptide Continuous Synthesizer Sales Market Share in Value by Type (2026-2031)
Table 21. Global Automatic Peptide Continuous Synthesizer Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)
Table 22. Global Automatic Peptide Continuous Synthesizer Sales Volume by Type (2020-2025) & (K Units)
Table 23. Global Automatic Peptide Continuous Synthesizer Sales Volume by Type (2026-2031) & (K Units)
Table 24. Global Automatic Peptide Continuous Synthesizer Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Automatic Peptide Continuous Synthesizer Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Automatic Peptide Continuous Synthesizer Price by Type (2020-2025) & (US$/Unit)
Table 27. Global Automatic Peptide Continuous Synthesizer Price by Type (2026-2031) & (US$/Unit)
Table 28. Global Automatic Peptide Continuous Synthesizer Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Automatic Peptide Continuous Synthesizer Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Automatic Peptide Continuous Synthesizer Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Automatic Peptide Continuous Synthesizer Sales Market Share in Value by Application (2020-2025)
Table 32. Global Automatic Peptide Continuous Synthesizer Sales Market Share in Value by Application (2026-2031)
Table 33. Global Automatic Peptide Continuous Synthesizer Sales Volume by Application: 2020 VS 2024 VS 2031 (K Units)
Table 34. Global Automatic Peptide Continuous Synthesizer Sales Volume by Application (2020-2025) & (K Units)
Table 35. Global Automatic Peptide Continuous Synthesizer Sales Volume by Application (2026-2031) & (K Units)
Table 36. Global Automatic Peptide Continuous Synthesizer Sales Market Share in Volume by Application (2020-2025)
Table 37. Global Automatic Peptide Continuous Synthesizer Sales Market Share in Volume by Application (2026-2031)
Table 38. Global Automatic Peptide Continuous Synthesizer Price by Application (2020-2025) & (US$/Unit)
Table 39. Global Automatic Peptide Continuous Synthesizer Price by Application (2026-2031) & (US$/Unit)
Table 40. Global Automatic Peptide Continuous Synthesizer Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Automatic Peptide Continuous Synthesizer Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Automatic Peptide Continuous Synthesizer Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Automatic Peptide Continuous Synthesizer Sales Value by Region (2020-2025) & (%)
Table 44. Global Automatic Peptide Continuous Synthesizer Sales Value by Region (2026-2031) & (%)
Table 45. Global Automatic Peptide Continuous Synthesizer Sales Volume by Region (K Units): 2020 VS 2024 VS 2031
Table 46. Global Automatic Peptide Continuous Synthesizer Sales Volume by Region (2020-2025) & (K Units)
Table 47. Global Automatic Peptide Continuous Synthesizer Sales Volume by Region (2026-2031) & (K Units)
Table 48. Global Automatic Peptide Continuous Synthesizer Sales Volume by Region (2020-2025) & (%)
Table 49. Global Automatic Peptide Continuous Synthesizer Sales Volume by Region (2026-2031) & (%)
Table 50. Global Automatic Peptide Continuous Synthesizer Average Price by Region (2020-2025) & (US$/Unit)
Table 51. Global Automatic Peptide Continuous Synthesizer Average Price by Region (2026-2031) & (US$/Unit)
Table 52. Key Countries/Regions Automatic Peptide Continuous Synthesizer Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Automatic Peptide Continuous Synthesizer Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Automatic Peptide Continuous Synthesizer Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Automatic Peptide Continuous Synthesizer Sales Volume, (2020-2025) & (K Units)
Table 56. Key Countries/Regions Automatic Peptide Continuous Synthesizer Sales Volume, (2026-2031) & (K Units)
Table 57. Gyros Protein Technologies AB Company Information
Table 58. Gyros Protein Technologies AB Introduction and Business Overview
Table 59. Gyros Protein Technologies AB Automatic Peptide Continuous Synthesizer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 60. Gyros Protein Technologies AB Automatic Peptide Continuous Synthesizer Product Offerings
Table 61. Gyros Protein Technologies AB Recent Development
Table 62. Büchi AG Company Information
Table 63. Büchi AG Introduction and Business Overview
Table 64. Büchi AG Automatic Peptide Continuous Synthesizer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 65. Büchi AG Automatic Peptide Continuous Synthesizer Product Offerings
Table 66. Büchi AG Recent Development
Table 67. Biotage Company Information
Table 68. Biotage Introduction and Business Overview
Table 69. Biotage Automatic Peptide Continuous Synthesizer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 70. Biotage Automatic Peptide Continuous Synthesizer Product Offerings
Table 71. Biotage Recent Development
Table 72. CEM Company Information
Table 73. CEM Introduction and Business Overview
Table 74. CEM Automatic Peptide Continuous Synthesizer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. CEM Automatic Peptide Continuous Synthesizer Product Offerings
Table 76. CEM Recent Development
Table 77. CSBio Company Information
Table 78. CSBio Introduction and Business Overview
Table 79. CSBio Automatic Peptide Continuous Synthesizer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. CSBio Automatic Peptide Continuous Synthesizer Product Offerings
Table 81. CSBio Recent Development
Table 82. AAPPTec Company Information
Table 83. AAPPTec Introduction and Business Overview
Table 84. AAPPTec Automatic Peptide Continuous Synthesizer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. AAPPTec Automatic Peptide Continuous Synthesizer Product Offerings
Table 86. AAPPTec Recent Development
Table 87. Activotec Company Information
Table 88. Activotec Introduction and Business Overview
Table 89. Activotec Automatic Peptide Continuous Synthesizer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Activotec Automatic Peptide Continuous Synthesizer Product Offerings
Table 91. Activotec Recent Development
Table 92. MultiSynTech Company Information
Table 93. MultiSynTech Introduction and Business Overview
Table 94. MultiSynTech Automatic Peptide Continuous Synthesizer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. MultiSynTech Automatic Peptide Continuous Synthesizer Product Offerings
Table 96. MultiSynTech Recent Development
Table 97. NJ Biopharmaceuticals LLC Company Information
Table 98. NJ Biopharmaceuticals LLC Introduction and Business Overview
Table 99. NJ Biopharmaceuticals LLC Automatic Peptide Continuous Synthesizer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 100. NJ Biopharmaceuticals LLC Automatic Peptide Continuous Synthesizer Product Offerings
Table 101. NJ Biopharmaceuticals LLC Recent Development
Table 102. Peptide Machines, Inc. Company Information
Table 103. Peptide Machines, Inc. Introduction and Business Overview
Table 104. Peptide Machines, Inc. Automatic Peptide Continuous Synthesizer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 105. Peptide Machines, Inc. Automatic Peptide Continuous Synthesizer Product Offerings
Table 106. Peptide Machines, Inc. Recent Development
Table 107. Protein Technologies, Inc. Company Information
Table 108. Protein Technologies, Inc. Introduction and Business Overview
Table 109. Protein Technologies, Inc. Automatic Peptide Continuous Synthesizer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 110. Protein Technologies, Inc. Automatic Peptide Continuous Synthesizer Product Offerings
Table 111. Protein Technologies, Inc. Recent Development
Table 112. Intavis AG Company Information
Table 113. Intavis AG Introduction and Business Overview
Table 114. Intavis AG Automatic Peptide Continuous Synthesizer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 115. Intavis AG Automatic Peptide Continuous Synthesizer Product Offerings
Table 116. Intavis AG Recent Development
Table 117. Key Raw Materials Lists
Table 118. Raw Materials Key Suppliers Lists
Table 119. Automatic Peptide Continuous Synthesizer Downstream Customers
Table 120. Automatic Peptide Continuous Synthesizer Distributors List
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
muLu

List of Figures

Figure 1. Automatic Peptide Continuous Synthesizer Product Picture
Figure 2. Global Automatic Peptide Continuous Synthesizer Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Automatic Peptide Continuous Synthesizer Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Automatic Peptide Continuous Synthesizer Sales Volume (2020-2031) & (K Units)
Figure 5. Global Automatic Peptide Continuous Synthesizer Sales Price (2020-2031) & (US$/Unit)
Figure 6. Automatic Peptide Continuous Synthesizer Report Years Considered
Figure 7. Global Automatic Peptide Continuous Synthesizer Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Automatic Peptide Continuous Synthesizer Players Sales Volume Ranking (2024) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Automatic Peptide Continuous Synthesizer Revenue in 2024
Figure 10. Automatic Peptide Continuous Synthesizer Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. Fully Automatic Picture
Figure 12. Aemi-automatic Picture
Figure 13. Manual Picture
Figure 14. Global Automatic Peptide Continuous Synthesizer Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 15. Global Automatic Peptide Continuous Synthesizer Sales Value Market Share by Type, 2024 & 2031
Figure 16. Global Automatic Peptide Continuous Synthesizer Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)
Figure 17. Global Automatic Peptide Continuous Synthesizer Sales Volume Market Share by Type, 2024 & 2031
Figure 18. Global Automatic Peptide Continuous Synthesizer Price by Type (2020-2031) & (US$/Unit)
Figure 19. Product Picture of Laboratory
Figure 20. Product Picture of University
Figure 21. Product Picture of Research Center
Figure 22. Global Automatic Peptide Continuous Synthesizer Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 23. Global Automatic Peptide Continuous Synthesizer Sales Value Market Share by Application, 2024 & 2031
Figure 24. Global Automatic Peptide Continuous Synthesizer Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units)
Figure 25. Global Automatic Peptide Continuous Synthesizer Sales Volume Market Share by Application, 2024 & 2031
Figure 26. Global Automatic Peptide Continuous Synthesizer Price by Application (2020-2031) & (US$/Unit)
Figure 27. North America Automatic Peptide Continuous Synthesizer Sales Value (2020-2031) & (US$ Million)
Figure 28. North America Automatic Peptide Continuous Synthesizer Sales Value by Country (%), 2024 VS 2031
Figure 29. Europe Automatic Peptide Continuous Synthesizer Sales Value, (2020-2031) & (US$ Million)
Figure 30. Europe Automatic Peptide Continuous Synthesizer Sales Value by Country (%), 2024 VS 2031
Figure 31. Asia Pacific Automatic Peptide Continuous Synthesizer Sales Value, (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Automatic Peptide Continuous Synthesizer Sales Value by Region (%), 2024 VS 2031
Figure 33. South America Automatic Peptide Continuous Synthesizer Sales Value, (2020-2031) & (US$ Million)
Figure 34. South America Automatic Peptide Continuous Synthesizer Sales Value by Country (%), 2024 VS 2031
Figure 35. Middle East & Africa Automatic Peptide Continuous Synthesizer Sales Value, (2020-2031) & (US$ Million)
Figure 36. Middle East & Africa Automatic Peptide Continuous Synthesizer Sales Value by Country (%), 2024 VS 2031
Figure 37. Key Countries/Regions Automatic Peptide Continuous Synthesizer Sales Value (%), (2020-2031)
Figure 38. Key Countries/Regions Automatic Peptide Continuous Synthesizer Sales Volume (%), (2020-2031)
Figure 39. United States Automatic Peptide Continuous Synthesizer Sales Value, (2020-2031) & (US$ Million)
Figure 40. United States Automatic Peptide Continuous Synthesizer Sales Value by Type (%), 2024 VS 2031
Figure 41. United States Automatic Peptide Continuous Synthesizer Sales Value by Application (%), 2024 VS 2031
Figure 42. Europe Automatic Peptide Continuous Synthesizer Sales Value, (2020-2031) & (US$ Million)
Figure 43. Europe Automatic Peptide Continuous Synthesizer Sales Value by Type (%), 2024 VS 2031
Figure 44. Europe Automatic Peptide Continuous Synthesizer Sales Value by Application (%), 2024 VS 2031
Figure 45. China Automatic Peptide Continuous Synthesizer Sales Value, (2020-2031) & (US$ Million)
Figure 46. China Automatic Peptide Continuous Synthesizer Sales Value by Type (%), 2024 VS 2031
Figure 47. China Automatic Peptide Continuous Synthesizer Sales Value by Application (%), 2024 VS 2031
Figure 48. Japan Automatic Peptide Continuous Synthesizer Sales Value, (2020-2031) & (US$ Million)
Figure 49. Japan Automatic Peptide Continuous Synthesizer Sales Value by Type (%), 2024 VS 2031
Figure 50. Japan Automatic Peptide Continuous Synthesizer Sales Value by Application (%), 2024 VS 2031
Figure 51. South Korea Automatic Peptide Continuous Synthesizer Sales Value, (2020-2031) & (US$ Million)
Figure 52. South Korea Automatic Peptide Continuous Synthesizer Sales Value by Type (%), 2024 VS 2031
Figure 53. South Korea Automatic Peptide Continuous Synthesizer Sales Value by Application (%), 2024 VS 2031
Figure 54. Southeast Asia Automatic Peptide Continuous Synthesizer Sales Value, (2020-2031) & (US$ Million)
Figure 55. Southeast Asia Automatic Peptide Continuous Synthesizer Sales Value by Type (%), 2024 VS 2031
Figure 56. Southeast Asia Automatic Peptide Continuous Synthesizer Sales Value by Application (%), 2024 VS 2031
Figure 57. India Automatic Peptide Continuous Synthesizer Sales Value, (2020-2031) & (US$ Million)
Figure 58. India Automatic Peptide Continuous Synthesizer Sales Value by Type (%), 2024 VS 2031
Figure 59. India Automatic Peptide Continuous Synthesizer Sales Value by Application (%), 2024 VS 2031
Figure 60. Automatic Peptide Continuous Synthesizer Industrial Chain
Figure 61. Automatic Peptide Continuous Synthesizer Manufacturing Cost Structure
Figure 62. Channels of Distribution (Direct Sales, and Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
den_biaoTiZhungShi

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Automatic Peptide Continuous Synthesizer market?zhanKai
The top companies in the global Automatic Peptide Continuous Synthesizer market are Gyros Protein Technologies AB、Büchi AG、Biotage.
What was the global market size of Automatic Peptide Continuous Synthesizer in 2031?shouQi
Which region is expected to have the highest market share?shouQi
What is the annual compound growth rate of the global Automatic Peptide Continuous Synthesizer market size from 2025 to 2031?shouQi
What was the global market size of Automatic Peptide Continuous Synthesizer in 2025?shouQi
den_biaoTiZhungShi

Related Reports

Automatic Peptide Continuous Synthesizer- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Medical Devices & Consumables

Published Date: 2025-01-13

Pages: 123 Pages

Report ld: 3501841

CHOOSE LICENSE TYPE
tip

USD 3950.00

tip

USD 5925.00

tip

USD 7900.00

Add to Cart

Add to Cart

Buy Now

Buy Now

HAVE A QUESTION?
SIMON LEE

English,Chinese

Offline

HITESH

English, Hindi

Online

TANG XIN

Japanese,English

Online

SUNG-BIN YOON

SUNG-BIN YOON

+82-2883 1278

Korean, English

Online

YUJIE TIAN

Chinese, English

Online

DAMON

Chinese, English

Online

General Email:

REPORT COVERAGE

den_ic8

DESCRIPTION

zhankai
den_ic7

OVERVIEW

den_ic7

MARKET SEGMENTATION

den_ic7

CHAPTER OUTLINE

den_ic7

QYRESEARCH'S STRENGTHS

den_ic8

TABLE OF CONTENTS

den_ic8

TABLE OF FIGURES

den_ic8

RLEATED REPORTS

INTEREST IN THIS REPORT?

yangBenGet A Free Sample

baoJia Request For Quotation

OR

NEED A CUSTOMIZED REPORT?

DingZhiCustomized Report

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now